Navigation Links
Sleep Centers

ProductsSleep Centers
Company MedCath Corporation
Item Sleep Centers
Features Turnkey Service

MedCath now offers turnkey development and management solutions to physicians interested in the provision of sleep medicine. MedCaths turnkey operation includes:

  • Facility site planning
  • Recruiting, hiring and training of all necessary personnel
  • Management of daily operations including scheduling, human resources, scoring and analysis assistance and billing/collections
  • New/Additional revenue source

A MedCath managed cardiac sleep center will ensure that your CVD patients are screened for SDB and diagnosed, treated and managed for this important cormorbidity.

MedCath can also demonstrate the advantages of creating a diagnostic center with additional service capabilities. A multi-disciplinary center can open treatment options, increase efficiency and broaden your potential patient base. We are experienced developers and managers of:

  • Nuclear Cardiology Programs
  • Cardiac Catheterization Laboratories
  • External Counterpulsation (ECP) Centers
Description Are You Aware of the High Prevalence of Sleep Disordered Breathing (SDB) in the Cardiovascular Disease Patient Population?

As Prevalent as Diabetes, with Vast Majority Undiagnosed Obstructive Sleep Apnea (OSA), the most common form of SDB, affects an estimated 18 million people in the United States. Only 5% of the OSA patients have been diagnosed, leaving millions untreated and at significant risk of serious complications.

DID YOU KNOW?

  • 80% of uncontrolled high blood pressure patients suffer from SDB
  • 60% of stroke patients suffer from SDB
  • 50% of congestive heart failure patients suffer from SDB
  • 45% of high blood pressure patients suffer from SDB

Severe Cardiovascular Co-Morbidities Left undetected and untreated, OSA significantly increases the risk of severe cardiovascular complications. In patients with coronary artery disease, sleep-disordered breathing is associated with a 60-70% increase in the risk of death and cardiovascular morbidity in long-term follow-up.

Is Your Practice Appropriately Screening and Testing Your Cardiovascular Disease Patient Population for SDB?

Info MedCath Corporation
Customer Service: (704) 708-6600
Web site: http://www.medcath.com

Related medicine products :

1. SleepWorks/Hyppo
2. Sleepscan VISION
3. Sleepscan Netlink Traveler
4. Easy II Sleep
5. Inspirex Sleep System
6. Capnocheck Sleep Capnograph/Oximeter
7. FingerPrint Sleep Hand-Held Pulse Oximeter/Summary Printer
8. Bivona® Sleep Apnea Tracheostomy Tubes
9. SleepStyle 604
10. SleepStyle 608
11. SleepStyle 232
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products:
(Date:4/14/2014)... orphaned by HIV/AIDS in South Africa may provide insight ... behavior issues in other areas of the world, which ... that could lead to successful interventions. , A ... United Nations mentions that due to the HIV/AIDS pandemic, ... African, children are at an increased risk for mental ...
(Date:4/14/2014)... A new study shows that moderate to severe ... risk of stroke, cancer and death. , Results of ... to severe obstructive sleep apnea were four times more ... times more likely to have a stroke (HR = ... (HR = 3.4), and 2.5 times more likely to ...
(Date:4/14/2014)... Dallas study involving serious youth offenders, the answer to one ... seven years: "How long do you think you,ll live?", According ... offending over time., Author Dr. Alex Piquero said the study ... of them offend at very high rates and commit more ... much later in life offend much less., "In a lot ...
(Date:4/14/2014)... with symptoms increasing dramatically during some of the most important ... has found. , Depressive symptoms increased on average by 68 ... young men, who were around 25 years old when they ... their children. The results of the study were published April ... is the first to identify when young fathers are at ...
(Date:4/14/2014)... Lower weight babies and babies who aren,t breastfed ... risk of developing chronic inflammation and related health ... study. , "There were good reasons to hypothesize ... inflammation in adulthood," says Thomas McDade (Northwestern University), ... in the Child & Brain Development program. "It ...
Breaking Medicine News(10 mins):Health News:Researchers identify children with emotional behavior difficulties 2Health News:Researchers identify children with emotional behavior difficulties 3Health News:Study links severe sleep apnea to increased risk of stroke, cancer and death 2Health News:UT Dallas study: Youth who fail to envision future commit more crimes 2Health News:Young dads at high risk of depression, too 2Health News:Low birth weight, less breastfeeding create later health risks 2
... The American,electorate has changed the course of history by ... that the messages of the Obama,presidency will be broader ... includes women. Lawrence Summers is not an appropriate choice ... The,contributions of science are important to the health of ...
... medications prove worth against the condition, doctors say , , ... new ways to use exercise and medications to manage ... a condition that affects more than 5 million Americans. ... percent reduction in death or hospitalization rates from any ...
... significant factors affect the spread of infectious diseases, including ... malaria" is a term coined by researchers to explain ... as the United States and Europe, which some scientists ... transmitted when a mosquito infected with the disease bites ...
... -- Pantheon China Acquisition,Corp. ("Pantheon", OTC Bulletin ... 2008 it entered into an agreement and ... Agreement") with China Cord Blood,Services Corporation ("CCBS") ... Company Limited ("Golden Meditech", Stock Code: 8180.HK),(collectively, ...
... VIEW, Calif., Nov. 11 Alexza,Pharmaceuticals, Inc. (Nasdaq: ALXA ... will present at the following investor conferences,in November and December:, ... The St. Regis Hotel 2 East 55th Street, New ... p.m. ET, 20th Annual Piper Jaffray Health Care Conference ...
... troubling trend , , TUESDAY, Nov. 11 (HealthDay News) -- ... for heart disease is slowing considerably. , In fact, ... starting at the beginning of the millennium. , "Dramatic ... of time, but now they,re leveling off," said Dr. ...
Cached Medicine News:Health News:Statement From the Rosalind Franklin Society: Lawrence Summers Not the Right Choice for Cabinet Position in Obama Administration 2Health News:Gains Against Heart Failure Reported 2Health News:Gains Against Heart Failure Reported 3Health News:'Airport malaria' -- cause for concern in the US 2Health News:Pantheon China Acquisition Corp. to Acquire China Cord Blood Services Corporation - Extension Proxy Filed With SEC 2Health News:Pantheon China Acquisition Corp. to Acquire China Cord Blood Services Corporation - Extension Proxy Filed With SEC 3Health News:Pantheon China Acquisition Corp. to Acquire China Cord Blood Services Corporation - Extension Proxy Filed With SEC 4Health News:Pantheon China Acquisition Corp. to Acquire China Cord Blood Services Corporation - Extension Proxy Filed With SEC 5Health News:Pantheon China Acquisition Corp. to Acquire China Cord Blood Services Corporation - Extension Proxy Filed With SEC 6Health News:Pantheon China Acquisition Corp. to Acquire China Cord Blood Services Corporation - Extension Proxy Filed With SEC 7Health News:Alexza Pharmaceuticals Announces Upcoming Conference Participation and Webcasts 2Health News:Alexza Pharmaceuticals Announces Upcoming Conference Participation and Webcasts 3Health News:After Decades, Decreases in Heart Risk Factors Level Off 2
(Date:1/15/2014)... , Jan. 15, 2014 ... report is available in its catalogue: ... India Drug Forecast and Market Analysis to ... PharmaPoint: Atopic Dermatitis - India Drug ... Summary,Although the past decade has seen ...
(Date:1/15/2014)... YORK , Jan. 15, 2014 /PRNewswire/ ... research report is available in its catalogue: ... Technologies for Advanced Drug Delivery Systems -- ... http://www.reportlinker.com/p01940411/Global-Markets-and-Technologies-for-Advanced-Drug-Delivery-Systems----Focus-on-End-Users.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Delivery_Technology STUDY OBJECTIVES ... of the very important aspects in today,s ...
(Date:1/15/2014)... Jan. 15, 2014  Zafgen, Inc., a leading ... of severely obese patients, today announced initial results ... selective inhibitor of methionine aminopeptidase 2 (MetAP2), in ... of genetic obesity.  These results showed improvements in ... reductions in body fat content and preserved lean ...
Breaking Medicine Technology:PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 2PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 4PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 5Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 2Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 3Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 4Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 5Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 6Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 7Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 8Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 9Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 10Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 11Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 12Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 13Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 14Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 15Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 16Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 17Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 18Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 2Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 4